The Present and the Future of Cost-Related Non-Adherence in Medicare Part D

被引:0
作者
William H. Shrank
Jennifer M. Polinski
机构
[1] CVS Health,
来源
Journal of General Internal Medicine | 2015年 / 30卷
关键词
Specialty Medication; Medicare Beneficiary; Cost Curve; Medicare Part; Total Healthcare Cost;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1045 / 1046
页数:1
相关论文
共 27 条
[1]  
Afendulis CC(2011)The impact of medicare Part D on hospitalization rates Health Serv Res 46 1022-38
[2]  
He Y(2012)Medicare part D’s impact on antipsychotic drug use and costs among elderly patients without prior drug insurance J Clin Psychopharmacol 32 3-10
[3]  
Zaslavsky AM(2011)Medicare Part D’s impact on the under- and over-use of medications: a systematic review J Am Geriatr Soc 59 1922-33
[4]  
Chernew ME(2011)The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money Health Aff 30 1351-7
[5]  
Polinski JM(2013)The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D J Am Geriatr Soc 61 1315-23
[6]  
Brookhart MA(2014)Specialty medications: traditional and novel tools can address rising spending on these costly drugs Health Aff 33 1736-44
[7]  
Glynn RJ(2014)Specialty drug spending trends among medicare and medicare advantage enrollees, 2007–11 Health Aff 33 2018-24
[8]  
Schneeweiss S(undefined)undefined undefined undefined undefined-undefined
[9]  
Polinski JM(undefined)undefined undefined undefined undefined-undefined
[10]  
Donahue JM(undefined)undefined undefined undefined undefined-undefined